| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.059 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |